Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2021-04-08 Major Shareholding Noti…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It details shareholding information of a promoter and persons acting in concert, including percentage holdings and voting rights. This type of disclosure is related to changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding details, confirming it is not a full report or announcement of a report publication. Therefore, the appropriate classification is MRQ.
2021-04-08 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from a company to the stock exchange about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of financial results for the year ended 31 March 2021 but does not contain any financial data or the results themselves. The document is an announcement related to regulatory compliance and trading restrictions, not a financial report or detailed filing. Given its short length (1443 characters) and content, it fits best as a Regulatory Filing (RNS) rather than a financial report or other specific filing type.
2021-03-31 English
Reply to Clarification Sought
Regulatory Filings Classification · 95% confidence The document is a detailed profile and service description of a company secretarial firm, M. R. Chechi & Associates, outlining their expertise in company law, securities laws, foreign direct investment, intellectual property rights, legal compliance audit, and legal advisory services. It includes information about the firm's leadership, services offered, and areas of specialization. There is no indication of this document being a financial report, regulatory filing, announcement, or any specific corporate filing type such as an annual report, earnings release, or management report. It is more of a corporate service profile or advisory firm brochure rather than a filing related to a company's financial or regulatory disclosures. Therefore, it does not fit into any of the specific filing categories defined. The closest fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not neatly fit into other categories.
2021-03-22 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding the allotment of bonus equity shares approved by the Board of Directors. It mentions the approval of allotment of bonus shares and requests the exchange to take note. The content is an announcement of a capital change (bonus shares issuance) rather than a full report or financial statement. The document length is short and it is clearly about a share capital change event. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2021-03-13 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the stock exchange reporting the outcome of a board meeting held on 13th March 2021. It mentions approval of allotment of bonus shares and appointment of a secretarial auditor. The document is short (1425 characters) and serves as an announcement of decisions made in the board meeting rather than a detailed report. It does not contain financial statements or detailed financial data. The content fits best under a Capital/Financing Update (CAP) because it announces a share allotment (bonus shares) and an auditor appointment related to company secretarial matters. It is not an Annual Report, Interim Report, or Regulatory Filing as it is specific to capital changes and board decisions. Therefore, the classification is CAP with high confidence.
2021-03-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.